Get your Human Gene Therapy paper right the first time: a ready-made structure with the right abstract and citations, so editors see your science, not formatting slips.
4.6
Authored by Sumalatha Gangadhar | Published on 13 August, 2026
Submitting to Human Gene Therapy goes smoothly when your draft already matches the journal's own rules. Editors screen new manuscripts against the Human Gene Therapy guide for authors before peer review, so formatting, structure, and required statements should be right on the first draft rather than repaired during upload. This template sets that structure up for you.
It is a manuscript shell aligned to Human Gene Therapy. It covers front matter, the abstract the journal expects, a body organized to the journal's article types, and a reference list in the journal's required style. Confirm current scope and article types on the Human Gene Therapy journal page before you draft.
Prepare the title, authors, affiliations, and ORCID iDs. Write the abstract to the journal's rule and word limit, organize the body to the article type, and apply the required reference style from the first citation. Complete every declaration (ethics, competing interests, funding, data availability) the Human Gene Therapy guide for authors lists, and cite figures and tables in order.
The common failure modes are formatting or reference style that does not match the guide for authors, missing required statements, and an incomplete portal checklist. Clear all three against the Human Gene Therapy guide for authors before you submit.
The shell mirrors what editorial staff check first: article-type fit, the abstract rules, required declarations, and the journal's reference style. For more detail see the author resources. When your draft is ready, upload it through ScholarOne (Manuscript Central).
| Element | Hum Gene Ther requirement |
|---|---|
| Abstract | Unstructured abstract with word limits varying by article type: Original Research Articles, Research Articles-Methods, Research Articles-Clinical Development, Review Articles, and Clinical Protocols require an unstructured abstract of no more than 300 words; Methods Protocols require an unstructured abstract of no more than 100 words; Pathways in Gene Therapy, Commentaries, News and Views, and Letters to the Editor require no abstract. For clinical trials, the trial registry name, URL, and registration number must be included at the end of the abstract |
| Main text | Main text word limits by article type: Original Research Articles (3,000 words), Review Articles (5,000-8,000 words), Research Articles-Methods (3,000 words), Research Articles-Clinical Development (3,000 words), Methods Protocols (3,000 words), Clinical Protocols (4,500 words), Pathways in Gene Therapy (2,000 words), Commentaries (1,200 words), News and Views (1,000 words), Letters to the Editor (500 words). Word limits do NOT pertain to the abstract, disclosure statements, author contribution statements, funding information, acknowledgments, tables, figure legends, or references |
| Declarations | Ethics approval/consent as applicable; competing interests; funding; data availability |
| Figures/tables | Publication-ready; cited in order |
| Supplemental | Upload separately when used |
| Keywords | Minimum of 4 keywords, listed after the abstract. Keywords should be as specific as possible to the research topic |
| References | Sage Vancouver reference style. In-text citations are superscripted numbers. Every in-text citation must have a corresponding citation in the reference list and vice versa. List 10 authors before adding et al |
| Peer review | Double-anonymized (double-blind): The journal adheres to a rigorous double-anonymized reviewing policy in which the identity of both the reviewer and author are always concealed from both parties. Note: The guide also lists 'Identity transparency: Single-anonymized' in the key information section, creating a contradiction, but the peer review policy section explicitly states double-anonymized |
| Submission | mc.manuscriptcentral.com/hum |
Read the Human Gene Therapy guide for authors once before drafting and once before upload. Draft the abstract after results are stable. Set the reference style before adding citations. Keep a cover letter that states your contribution and fit to Human Gene Therapy in under a page.
Skim two or three recent Hum Gene Ther papers to calibrate depth and figure style. Make the novelty clear in the first two pages. Deposit data and code when the policy on the Human Gene Therapy journal page requires it. Disclose any preprint or conference version with identifiers in the cover letter.
Do one focused pass against the Human Gene Therapy guide for authors: scope, length, reference style, required declarations, and figure quality. Then submit through ScholarOne (Manuscript Central).